Cutler Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,300
Closed -$34K 4341
2022
Q4
$34K Sell
13,300
-12,000
-47% -$973K ﹤0.01% 1845
2022
Q3
$209K Sell
25,300
-7,000
-22% -$629K 0.01% 937
2022
Q2
$228K Buy
32,300
+15,000
+87% +$1.52M 0.02% 927
2022
Q1
$40K Buy
17,300
+17,100
+8,550% +$1.81M ﹤0.01% 2436
2021
Q4
$1K Buy
+200
New +$23.2K ﹤0.01% 5059
2021
Q1
Sell
-9,600
Closed -$1K 6027
2020
Q4
$1K Buy
+9,600
New +$1.06M ﹤0.01% 4476
2020
Q3
Sell
-2,000
Closed -$4K 5027
2020
Q2
$4K Buy
2,000
+500
+33% +$47.9K ﹤0.01% 3474
2020
Q1
$20K Buy
+1,500
New +$160K ﹤0.01% 2313
2017
Q1
Sell
-8,100
Closed -$31K 6868
2016
Q4
$31K Buy
8,100
+3,100
+62% +$244K ﹤0.01% 3021
2016
Q3
$4K Sell
5,000
-10,000
-67% -$871K ﹤0.01% 5156
2016
Q2
$10K Buy
15,000
+5,000
+50% +$404K ﹤0.01% 4144
2016
Q1
$3K Sell
10,000
-8,600
-46% -$648K ﹤0.01% 5290
2015
Q4
$1K Buy
+18,600
New +$1.4M ﹤0.01% 5989

Other funds holding MDT

Cutler Group's MDT Position: Q1 2023 in Review

Cutler Group sold out of Medtronic (MDT) in Q1 2023, closing a stake of 5,559 shares — an estimated $453K sold.

Cutler Group first reported a position in MDT in Q4 2015 and held it in 15 quarters. The position peaked at $3.36M in Q1 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Cutler Group reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,559 Medtronic shares in Q1 2023, an estimated $453K.
  • Cutler Group first reported a position in Medtronic in Q4 2015 and held it in 15 quarters.
  • Cutler Group's Medtronic position peaked at $3.36M in Q1 2022.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.